期刊文献+

Effects of Combined Treatment with Sansanmycin and Macrolides on Pseudomonas aeruginosa and Formation of Biofilm 被引量:3

Effects of Combined Treatment with Sansanmycin and Macrolides on Pseudomonas aeruginosa and Formation of Biofilm
下载PDF
导出
摘要 Objective To observe the effects of combined treatment with sansanmycin and macrolides on Pseudomonas aeruginosa and formation of biofilm. Methods Micro-dilution method was used to determine the minimal inhibitory concentrations (MICs) of sansanmycin, gentamycin, carbenicillin, polymyxin B, roxithromycin, piperacillin, and tazobactam. PAl and PA27853 biofilms were observed under optical microscope after staining and under SEM after treatment with sansanmycin at different dosages and combined treatment with sansanmycin and roxithromycin. Viable bacteria in PAl and PA27853 biofilms were counted after treatment with sansanmycin at different dosages or combined treatment with sansanmycin and roxithromycin. Results The MIC of sansanmycin was lower than that of gentamycin and polymyxin B, but was higher than that of carbenicillin. Roxithromycin enhanced the penetration of sansanmycin to PAl and PA27853 strains through biofilms. PAl and PA27853 biofilms were gradually cleared with the increased dosages of sansanmycin or with the combined sansanmycin and roxithromycin. Conclusion Sub-MIC levels of roxithromycin and sansanmycin substantially inhibit the generation of biofilms and proliferation of bacteria. Therefore, combined antibiotics can be used in treatment of intractable bacterial infection. Objective To observe the effects of combined treatment with sansanmycin and macrolides on Pseudomonas aeruginosa and formation of biofilm. Methods Micro-dilution method was used to determine the minimal inhibitory concentrations (MICs) of sansanmycin, gentamycin, carbenicillin, polymyxin B, roxithromycin, piperacillin, and tazobactam. PAl and PA27853 biofilms were observed under optical microscope after staining and under SEM after treatment with sansanmycin at different dosages and combined treatment with sansanmycin and roxithromycin. Viable bacteria in PAl and PA27853 biofilms were counted after treatment with sansanmycin at different dosages or combined treatment with sansanmycin and roxithromycin. Results The MIC of sansanmycin was lower than that of gentamycin and polymyxin B, but was higher than that of carbenicillin. Roxithromycin enhanced the penetration of sansanmycin to PAl and PA27853 strains through biofilms. PAl and PA27853 biofilms were gradually cleared with the increased dosages of sansanmycin or with the combined sansanmycin and roxithromycin. Conclusion Sub-MIC levels of roxithromycin and sansanmycin substantially inhibit the generation of biofilms and proliferation of bacteria. Therefore, combined antibiotics can be used in treatment of intractable bacterial infection.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2009年第2期170-177,共8页 生物医学与环境科学(英文版)
关键词 Sansanmycin MACROLIDES Pseudomonas aeruginosa BIOFILM Sansanmycin Macrolides Pseudomonas aeruginosa Biofilm
  • 相关文献

参考文献23

  • 1Yunying Xie , Ruxian Chen, Shuyi Si, et al. (2007). A new Nucleosidyl-peptide Antibiotic, Sansanmycin. J Antibiot 60, 158-161.
  • 2Cachia P J, Hodges R S (2003). Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Biopolymers 71, 141-168.
  • 3Saiman L, Sieqel J (2004). Infection control in cystic fibrosis J.Clin Microbiol 17, 57-71.
  • 4Lindsay D, von Holy A (2006). Bacterial biofilms within the clinical setting: what healthcare professionals should know. J Hosp Infect 64, 313-325.
  • 5Drenkard E (2003).Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5, 1213-1219.
  • 6Stover C K, Pham X Q, Erwin A L, et al. (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1 an opportunistic Pathogen. Nature 406, 959-964.
  • 7Poole K (2001). Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3, 255-264.
  • 8Livermore D M (2001). Of Pseudomonas, porins, pumps and carbapenems. Journal of Antimicrobial Chemotherapy 47, 247-250.
  • 9Vahaboglu H, Coskunkan F, Tansel O, et al. (2001). Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol 50, 642-645.
  • 10Lanmert P A (2002). Mechanisms of antibiotic resistance in Pseudomonas Aeruginosa. J R Soc Med 95, 22-26.

同被引文献18

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部